Carnegie Center for Art & History

Kyowa Kirin Designs New North American Headquarters to Accelerate Innovation, Collaboration, Culture

Retrieved on: 
Tuesday, July 11, 2023
Workforce, Human resources, Senior, Carnegie Center for Art & History, Princeton Academy of the Sacred Heart, Workplace, Kyowa Kirin, Research, Patient, Environment, TSE, Fine chemical, Management

PRINCETON, N.J., July 11, 2023 /PRNewswire/ -- Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company based in Japan, today announces the completion of its new North America headquarters at 510 Carnegie Center in Princeton, NJ. The new space will host over 300 employees – across various functions that support all phases of the product life cycle including development, commercial and corporate functions – combining teams that used to be split across two New Jersey locations into one space, specially outfitted to foster the company's culture of collaboration and innovation.

Key Points: 
  • Japan-Based Specialty Pharmaceutical Company Moves Into Princeton, NJ, Offices
    PRINCETON, N.J., July 11, 2023 /PRNewswire/ -- Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company based in Japan, today announces the completion of its new North America headquarters at 510 Carnegie Center in Princeton, NJ.
  • "Bringing our teams into one shared location will enable us to work more collaboratively across the lifecycle as we focus on increasing our impact and work for patients and their families," said Kyowa Kirin North America President Steve Schaefer.
  • North America is the company's fastest-growing region in terms of revenue, contributing more than a quarter of Kyowa Kirin's global revenues in 2022, up from 13% in 2019.
  • During that same time, the company nearly doubled its number of North American employees to more than 600.

Lauded Neurosurgeon, Researcher and Inventor Nicholas Theodore, MD Joins Harvard MedTech’s Medical Advisory Board

Retrieved on: 
Tuesday, January 10, 2023
Mental Health, Medical Devices, Health, Surgery, Research, Science, Brain, Algorithm, Metabolic pathway, Mike Donlin, Depression, Johns Hopkins, Anxiety, Barrow Neurological Institute, DARPA, Defense, MD, Department of Defense Serum Repository, Harvard University, Johns Hopkins School of Medicine, Spine, Patient, Research, FACS, Neurosurgery, Carnegie Center for Art & History, Surgical Innovation, Pain management, Medtech, Pain, Pharmaceutical industry, Medical device, Medical imaging

Nationally recognized neurosurgeon Nicholas Theodore, MS, MD, FAANS, FACS has accepted an invitation to join the Medical Advisory Board of Harvard MedTech , announced Gerry Stanley, M.D., Chief Medical Officer at Harvard MedTech.

Key Points: 
  • Nationally recognized neurosurgeon Nicholas Theodore, MS, MD, FAANS, FACS has accepted an invitation to join the Medical Advisory Board of Harvard MedTech , announced Gerry Stanley, M.D., Chief Medical Officer at Harvard MedTech.
  • Theodore is the Director of the Neurosurgical Spine Program at the most prestigious neurosurgical program in the country,” noted Dr. Stanley.
  • “In addition to his surgical innovations and research endeavors, Dr. Theodore holds over 20 patents for medical devices and procedures.
  • The purpose of the Harvard MedTech Medical Advisory Board is to facilitate industry-wide adoption of Vx® Therapy in the treatment of workplace trauma.

BXP Sees Strong Leasing Momentum in the 4th Quarter 2021

Retrieved on: 
Tuesday, January 25, 2022
Commercial Building & Real Estate, Construction & Property, REIT, Carnegie Center for Art & History, NYSE, REIT, Property, Main Street, Gateway, Growth, Reston Town Center, BXP, Instagram, LinkedIn, Company, Boston Properties, Lexington Avenue, Times Square Tower, CEO, Self storage, Tunnel

The strong leasing momentum we experienced in the fourth quarter underscores the value companies place on securing high-quality workspaces essential for collaboration, innovation, and growth, said Owen Thomas, CEO, BXP.

Key Points: 
  • The strong leasing momentum we experienced in the fourth quarter underscores the value companies place on securing high-quality workspaces essential for collaboration, innovation, and growth, said Owen Thomas, CEO, BXP.
  • BXPs leasing activity steadily increased throughout 2021 with the fourth quarter achieving the largest square footage leased since Q3 of 2019s 2 million square feet and it represents a 55% increase from Q4 of 2020.
  • More than 25% of the square footage signed this quarter was leased to life sciences clients demonstrating the strong demand in BXPs growing life science portfolio.
  • Leasing with clients in other industry groups have also accelerated during 2021 and contributed to BXPs expanding leasing velocity.